HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Field, C. J Articles by Schley, P. D Search for Related Content PubMed PubMed Citation Articles by Field, C. J Articles by Schley, P. D Agricola Articles by Field, C. J Articles by Schley, P. D

Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n–3 fatty acids^1,2,3,4

¹ From the Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Canada

ABSTRACT

Conjugated linoleic acid (CLA) and the long-chain polyunsaturated n–3 fatty acids have been shown in vivo and in vitro to reduce tumor growth. Tumor growth could occur by slowing or stopping cell replication (by interfering with transition through the cell cycle), increasing cell death (via necrosis and/or apoptosis), or both. The anticancer effects of fatty acids, shown in vivo, could also be mediated by effects on the host’s immune system. Although it is widely recognized that n–3 fatty acids can alter immune and inflammatory responses, considerably less is known about CLA. For n–3 fatty acids, several candidate mechanisms have been proposed for their immune effects, including changes in 1) membrane structure and composition, 2) membrane-mediated functions and signals (eg, proteins, eicosanoids), 3) gene expression, and 4) immune development. Considerable work has been done that shows the potential importance of CLA as an anticancer treatment; however, many questions remain as to how this effect occurs. This review summarizes the CLA and cancer literature and then uses the evidence for the anticancer immune and tumor properties of the long-chain n–3 fatty acids docosahexaenoic and eicosapentaenoic acids to suggest future research directions for mechanistic studies on CLA and cancer.

Key Words: Docosahexaenoic acid • eicosapentaenoic acid • cancer • mammary tumors • apoptosis • necrosis • cell cycle • rodents

This article has been cited by other articles:

				D. E. Butz, G. Li, S. M. Huebner, and M. E. Cook A mechanistic approach to understanding conjugated linoleic acid's role in inflammation using murine models of rheumatoid arthritis Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R669 - R676. [Abstract] [Full Text] [PDF]

				M. L. Neuhouser, M. J. Barnett, A. R. Kristal, C. B. Ambrosone, I. King, M. Thornquist, and G. Goodman (n-6) PUFA Increase and Dairy Foods Decrease Prostate Cancer Risk in Heavy Smokers J. Nutr., July 1, 2007; 137(7): 1821 - 1827. [Abstract] [Full Text] [PDF]

				A. Storey, J. S. Rogers, F. McArdle, M. J. Jackson, and L. E. Rhodes Conjugated linoleic acids modulate UVR-induced IL-8 and PGE2 in human skin cells: potential of CLA isomers in nutritional photoprotection Carcinogenesis, June 1, 2007; 28(6): 1329 - 1333. [Abstract] [Full Text] [PDF]

				J. B. Ewaschuk, J. W. Walker, H. Diaz, and K. L. Madsen Bioproduction of Conjugated Linoleic Acid by Probiotic Bacteria Occurs In Vitro and In Vivo in Mice J. Nutr., June 1, 2006; 136(6): 1483 - 1487. [Abstract] [Full Text] [PDF]

				J. Polesel, R. Talamini, M. Montella, M. Parpinel, L. Dal Maso, A. Crispo, M. Crovatto, M. Spina, C. La Vecchia, and S. Franceschi Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study Ann. Onc., April 1, 2006; 17(4): 713 - 718. [Abstract] [Full Text] [PDF]